The present isolated tissue study was designed to quantitate the α-adrenoceptor agonist activity of AY- 30,191 and a series of related compounds(I)(R= substituted aminoethyl, Et, HOCH2, H2NCH2 or HON:CH; R1=H or Me; R2=e.g.,H or CONH2, 2,3-saturated or unsaturated).AY-30,191 induced contractions in the rabbit aorta, which were blocked by prazosin.In the rat vas deferens, while clonidine inhibited the elec. induced twitch response, AY-30,191 caused a prazosin-sensitive augmentation.In the dog saphenous vein, rauwolscine was less effective than the combination of rauwolscine and prazosin in inhibiting the contractions induced by AY-30,191.Pretreatment of the dog saphenous vein with phenoxybenzamine reduced the response to AY-30,191.The addition of rauwolscine to phenoxybenzamine-treated tissues had no effect on the contractions to AY-30,191 remaining after phenoxybenzamine treatment.Thus, AY-30,191 is a selective α1-adrenoceptor agonist.Optimal α1-adrenoceptor agonist activity in the 1H-indole-7-carboxamide series was seen in compounds in which a) the indole ring and the ethylamine side chain were intact; b) the indole N was unsubstituted; and c) the carboxamide was present at the 7-position in the indole ring.Removal of the carboxamide decreased α1-adrenoceptor activity and, more importantly, resulted in a loss of α1-adrenoceptor selectivity.Replacement of the carboxamide in the 7 position with methanesulfonamide resulted in a decrease in activity but a retention of α1-adrenoceptor selectivity, whereas the dimethylamino analog was nonselective and the phosphoramidic acid diethylester analog was inactive.Thus, the 1H-indole-7-carboxamides are a novel series of selective α1-adrenoceptor agonists and substitution at the 7 position determines α1-adrenoceptor selectivity.